LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Estimate of vertical transmission of Hepatitis C virus in Pakistan in 2007 and 2012 birth cohorts.

    Benova, Lenka / Awad, Susanne Faissal / Abu-Raddad, Laith Jamal

    Journal of viral hepatitis

    2017  Volume 24, Issue 12, Page(s) 1177–1183

    Abstract: Despite a combination of high Hepatitis C virus (HCV) prevalence, a large adult population and high fertility, no published estimates of the scale and contribution of vertical transmission to HCV incidence in Pakistan exist. The objective of this study ... ...

    Abstract Despite a combination of high Hepatitis C virus (HCV) prevalence, a large adult population and high fertility, no published estimates of the scale and contribution of vertical transmission to HCV incidence in Pakistan exist. The objective of this study was to estimate the number of new HCV infections occurring in Pakistan as a result of vertical transmission. We adapted a published mathematical model based on HCV antibody and viraemia prevalence, fertility rates, risk of HCV vertical transmission and children mortality rates to estimate the number of infections in the 2007 and 2012 birth cohorts nationally and in four subnational regions. We estimated that 19 708 (95% uncertainty interval [UI]: 15 941-23 819) children were vertically infected by HCV in 2007 and 21 676 (95% UI: 17 498-26 126) in 2012. The majority of these cases (72.9% and 72.5% in 2007 and 2012, respectively) occurred in Punjab. We estimated that vertical transmission as a mode of exposure accounted for a quarter of HCV infections among children under 5 years of age (25.2% in 2007 and 24.0% in 2012).
    Conclusion: Our results showed that one in 260 children born in Pakistan in 2007 and 2012 acquired HCV vertically. While currently no interventions during pregnancy and childbirth are recommended to reduce this risk, prevention, testing and treatment strategies should be considered to reduce the burden of vertical HCV infections among young children. Other routes of transmission appear to contribute the majority of HCV infections among children and must also be clarified and urgently addressed.
    MeSH term(s) Adolescent ; Adult ; Cohort Studies ; Female ; Hepatitis C/epidemiology ; Hepatitis C/transmission ; Humans ; Incidence ; Infant ; Infant, Newborn ; Infectious Disease Transmission, Vertical ; Male ; Middle Aged ; Models, Theoretical ; Pakistan/epidemiology ; Young Adult
    Language English
    Publishing date 2017
    Publishing country England
    Document type Journal Article
    ZDB-ID 1212497-7
    ISSN 1365-2893 ; 1352-0504
    ISSN (online) 1365-2893
    ISSN 1352-0504
    DOI 10.1111/jvh.12748
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Leveraging wastewater surveillance for managing the spread of SARS-CoV-2 and concerned pathogens during FIFA World Cup Qatar 2022.

    El-Malah, Shimaa S / Saththasivam, Jayaprakash / K, Arun K / Abdul Jabbar, Khadeeja / Gomez, Tricia A / Wahib, Sara / Lawler, Jenny / Tang, Patrick / Mirza, Faheem / Al-Hail, Hamad / Ouararhni, Khalid / Abdul Azis, Thasni K / Abu Raddad, Laith Jamal / Chemaitelly, Hiam S / Abu Halaweh, Hussein A / Khalife, Sara / Bertollini, Roberto / Mahmoud, Khaled A

    Heliyon

    2024  Volume 10, Issue 9, Page(s) e30267

    Abstract: Wastewater-based epidemiology (WBE) has been proven effective for the monitoring of infectious disease outbreaks during mass gathering events and for timely public health interventions. As part of Qatar's efforts to monitor and combat the spread of ... ...

    Abstract Wastewater-based epidemiology (WBE) has been proven effective for the monitoring of infectious disease outbreaks during mass gathering events and for timely public health interventions. As part of Qatar's efforts to monitor and combat the spread of infectious diseases during the FIFA World Cup Qatar 2022™ (FWC'22), wastewater surveillance was used to monitor the spread of SARS-CoV-2, human enterovirus, and poliovirus. The screening covered five major wastewater treatment plants servicing the event locations between October 2022 and January 2023. Viruses were concentrated from the wastewater samples by PEG precipitation, followed by qRT-PCR to measure the viral load in the wastewater. As expected, SARS-CoV-2 and enterovirus RNA were detected in all samples, while poliovirus was not detected. The concentration of SARS-CoV-2 was correlated with population density, such as areas surrounding the World Cup venues, and with the number of reported clinical cases. Additionally, we observed temporal fluctuations in viral RNA concentrations, with peak levels coinciding with the group stage matches of the FWC'22. This study has been useful in providing public health authorities with an efficient and cost-effective surveillance system for potential infectious disease outbreaks during mega-events.
    Language English
    Publishing date 2024-04-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2024.e30267
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Retrospective evaluation of a TEN/SJS series managed with a new treatment protocol.

    Steinhoff, Martin / Buddenkotte, Joerg / Al-Shafi, Wadha / Al-Marri, Hissa / Emam, Fatima / Iqneibi, Mariam / Harris, Tim Richard Edmund / Thomas, Stephen H / Asad, Syed Muhammad / Al-Maslamani, Hanan / Joy, Febu Elizabeth / Therachiyil, Lubna / Jochebeth, Anh / Leo, Rari / Younis, Shahad M / Abu Raddad, Laith Jamal / Dargham, Soha Roger / Al-Khawaga, Sara

    Journal of the European Academy of Dermatology and Venereology : JEADV

    2024  

    Language English
    Publishing date 2024-05-07
    Publishing country England
    Document type Letter
    ZDB-ID 1128828-0
    ISSN 1468-3083 ; 0926-9959
    ISSN (online) 1468-3083
    ISSN 0926-9959
    DOI 10.1111/jdv.20060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.

    Hasan, Mohammad Rubayet / Ahmad, Muneera Naseer / Dargham, Soha Roger / Zayed, Hatem / Al Hashemi, Alaa / Ngwabi, Nonhlanhla / Perez Lopez, Andres / Dobson, Simon / Abu Raddad, Laith Jamal / Tang, Patrick

    Microbiology spectrum

    2021  Volume 9, Issue 3, Page(s) e0078321

    Abstract: Lower levels of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in the nasal epithelium of children may be related to a lower incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, ... ...

    Abstract Lower levels of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in the nasal epithelium of children may be related to a lower incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, compared to adults. However, no direct evidence is available to support this hypothesis. In this study, we compared the transcript levels of ACE2 and TMPRSS2 in nasopharyngeal swab samples (
    MeSH term(s) Adult ; Angiotensin-Converting Enzyme 2/genetics ; Angiotensin-Converting Enzyme 2/metabolism ; COVID-19/metabolism ; Child ; Child, Preschool ; Female ; Gene Expression ; Humans ; Infant ; Male ; Nasopharynx/metabolism ; Nasopharynx/virology ; SARS-CoV-2 ; Serine Endopeptidases/genetics ; Serine Endopeptidases/metabolism ; Serine Proteases/metabolism ; Specimen Handling
    Chemical Substances Serine Proteases (EC 3.4.-) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Serine Endopeptidases (EC 3.4.21.-) ; TMPRSS2 protein, human (EC 3.4.21.-) ; transmembrane serine protease 2, human (EC 3.4.21.-)
    Language English
    Publishing date 2021-11-03
    Publishing country United States
    Document type Journal Article
    ISSN 2165-0497
    ISSN (online) 2165-0497
    DOI 10.1128/Spectrum.00783-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Erratum

    Stanaway, Jeffrey D. / Afshin, Ashkan / Gakidou, Emmanuela / Lim, Stephen S. / Abate, Degu / Abate, Kalkidan Hassen / Abbafati, Cristiana / Abbasi, Nooshin / Abbastabar, Hedayat / Abd-Allah, Foad / Abdela, Jemal / Abdelalim, Ahmed / Abdollahpour, Ibrahim / Abdulkader, Rizwan Suliankatchi / Abebe, Molla / Abebe, Zegeye / Abera, Semaw F. / Abil, Olifan Zewdie / Abraha, Haftom Niguse /
    Abrham, Aklilu Roba / Abu-Raddad, Laith Jamal / Abu-Rmeileh, Niveen M.E. / Accrombessi, Manfred Mario Kokou / Acharya, Dilaram / Acharya, Pawan / Adamu, Abdu A. / Adane, Akilew Awoke / Adebayo, Oladimeji M. / Adedoyin, Rufus Adesoji / Adekanmbi, Victor / Ademi, Zanfina / Adetokunboh, Olatunji O. / Adib, Mina G. / Admasie, Amha / Adsuar, Jose C. / Afanvi, Kossivi Agbelenko / Afarideh, Mohsen / Agarwal, Gina / Aggarwal, Anju / Aghayan, Sargis Aghasi / Geleijnse, Johanna M. / Hoek, Hans W. / Khan, Muhammad Shahzeb / Nguyen, Ha Thu / Nguyen, Huong Lan Thi / Vos, Theo / Zhang, Hao / Zhang, Kai

    The Lancet

    Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    2019  Volume 393, Issue 10190

    Abstract: Background The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk– ... ...

    Abstract Background The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associations. Methods We used the CRA framework developed for previous iterations of GBD to estimate levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs), by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017. This study included 476 risk–outcome pairs that met the GBD study criteria for convincing or probable evidence of causation. We extracted relative risk and exposure estimates from 46 749 randomised controlled trials, cohort studies, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. Using the counterfactual scenario of theoretical minimum risk exposure level (TMREL), we estimated the portion of deaths and DALYs that could be attributed to a given risk. We explored the relationship between development and risk exposure by modelling the relationship between the Socio-demographic Index (SDI) and risk-weighted exposure prevalence and estimated expected levels of exposure and risk-attributable burden by SDI. Finally, we explored temporal changes in risk-attributable DALYs by decomposing those changes into six main component drivers of change as follows: (1) population growth; (2) changes in population age structures; (3) changes in exposure to environmental and occupational risks; (4) changes in exposure to behavioural risks; (5) changes in exposure to metabolic risks; and (6) changes due to all other factors, approximated as the ...
    Keywords Life Science
    Subject code 333
    Language English
    Publishing country nl
    Document type Article ; Online
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017

    Kyu, Hmwe Hmwe / Abate, Degu / Abate, Kalkidan Hassen / Abay, Solomon M. / Abbafati, Cristiana / Abbasi, Nooshin / Abbastabar, Hedayat / Abd-Allah, Foad / Abdela, Jemal / Abdelalim, Ahmed / Abdollahpour, Ibrahim / Abdulkader, Rizwan Suliankatchi / Abebe, Molla / Abebe, Zegeye / Abil, Olifan Zewdie / Aboyans, Victor / Abrham, Aklilu Roba / Abu-Raddad, Laith Jamal / Abu-Rmeileh, Niveen M.E. /
    Accrombessi, Manfred Mario Kokou / Acharya, Dilaram / Acharya, Pawan / Ackerman, Ilana N. / Adamu, Abdu A. / Adebayo, Oladimeji M. / Adekanmbi, Victor / Ademi, Zanfina / Adetokunboh, Olatunji O. / Adib, Mina G. / Adsuar, Jose C. / Afanvi, Kossivi Agbelenko / Afarideh, Mohsen / Afshin, Ashkan / Agarwal, Gina / Agesa, Kareha M. / Aggarwal, Rakesh / Aghayan, Sargis Aghasi / Agrawal, Anurag / Ahmadi, Alireza / Ahmadi, Mehdi / Ahmadieh, Hamid / Ahmed, Muktar Beshir / Hoek, Hans W. / Khan, Muhammad Ali / Nguyen, Ha Thu / Nguyen, Huong Thanh / Nguyen, Son Hoang / Vos, Theo

    The Lancet

    A systematic analysis for the Global Burden of Disease Study 2017

    2018  Volume 392, Issue 10159

    Abstract: Background: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We ...

    Abstract Background: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure of disability-adjusted lifeyears (DALYs), a composite measure of disease burden capturing both premature mortality and prevalence and severityof ill health, for 359 diseases and injuries for 195 countries and territories over the past 28 years. Methods We used data for age-speci?c mortality rates, years of life lost (YLLs) due to premature mortality, and years lived with disability (YLDs) from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to calculate HALE and DALYs from 1990 to 2017. We calculated HALE using age-specific mortality rates and YLDs per capita for each location, age, sex, and year. We calculated DALYs for 359 causes as the sum of YLLs and YLDs. We assessed how observed HALE and DALYs differed by country and sex from expected trends based on Sociodemographic Index (SDI). We also analysed HALE by decomposing years of life gained into years spent in good health and in poor health, between 1990 and 2017, and extra years lived by females compared with males. Findings Globally, from 1990 to 2017, life expectancy at birth increased by 7·4 years (95% uncertainty interval 7·1-7·8), from 65·6 years (65·3-65·8) in 1990 to 73·0 years (72·7-73·3) in 2017. The increase in years of life varied from 5·1 years (5·0-5·3) in high SDI countries to 12·0 years (11·3-12·8) in low SDI countries. Of the additional years of life expected at birth, 26·3% (20·1-33·1) were expected to be spent in poor health in high SDI countries compared with 11·7% (8·8-15·1) in low-middle SDI countries. HALE at birth increased by 6·3 years (5·9-6·7), from 57·0 years ...
    Keywords Life Science
    Subject code 360
    Language English
    Publishing country nl
    Document type Article ; Online
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.

    Fitzmaurice, Christina / Abate, Degu / Abbasi, Naghmeh / Abbastabar, Hedayat / Abd-Allah, Foad / Abdel-Rahman, Omar / Abdelalim, Ahmed / Abdoli, Amir / Abdollahpour, Ibrahim / Abdulle, Abdishakur S M / Abebe, Nebiyu Dereje / Abraha, Haftom Niguse / Abu-Raddad, Laith Jamal / Abualhasan, Ahmed / Adedeji, Isaac Akinkunmi / Advani, Shailesh M / Afarideh, Mohsen / Afshari, Mahdi / Aghaali, Mohammad /
    Agius, Dominic / Agrawal, Sutapa / Ahmadi, Ayat / Ahmadian, Elham / Ahmadpour, Ehsan / Ahmed, Muktar Beshir / Akbari, Mohammad Esmaeil / Akinyemiju, Tomi / Al-Aly, Ziyad / AlAbdulKader, Assim M / Alahdab, Fares / Alam, Tahiya / Alamene, Genet Melak / Alemnew, Birhan Tamene T / Alene, Kefyalew Addis / Alinia, Cyrus / Alipour, Vahid / Aljunid, Syed Mohamed / Bakeshei, Fatemeh Allah / Almadi, Majid Abdulrahman Hamad / Almasi-Hashiani, Amir / Alsharif, Ubai / Alsowaidi, Shirina / Alvis-Guzman, Nelson / Amini, Erfan / Amini, Saeed / Amoako, Yaw Ampem / Anbari, Zohreh / Anber, Nahla Hamed / Andrei, Catalina Liliana / Anjomshoa, Mina / Ansari, Fereshteh / Ansariadi, Ansariadi / Appiah, Seth Christopher Yaw / Arab-Zozani, Morteza / Arabloo, Jalal / Arefi, Zohreh / Aremu, Olatunde / Areri, Habtamu Abera / Artaman, Al / Asayesh, Hamid / Asfaw, Ephrem Tsegay / Ashagre, Alebachew Fasil / Assadi, Reza / Ataeinia, Bahar / Atalay, Hagos Tasew / Ataro, Zerihun / Atique, Suleman / Ausloos, Marcel / Avila-Burgos, Leticia / Avokpaho, Euripide F G A / Awasthi, Ashish / Awoke, Nefsu / Ayala Quintanilla, Beatriz Paulina / Ayanore, Martin Amogre / Ayele, Henok Tadesse / Babaee, Ebrahim / Bacha, Umar / Badawi, Alaa / Bagherzadeh, Mojtaba / Bagli, Eleni / Balakrishnan, Senthilkumar / Balouchi, Abbas / Bärnighausen, Till Winfried / Battista, Robert J / Behzadifar, Masoud / Behzadifar, Meysam / Bekele, Bayu Begashaw / Belay, Yared Belete / Belayneh, Yaschilal Muche / Berfield, Kathleen Kim Sachiko / Berhane, Adugnaw / Bernabe, Eduardo / Beuran, Mircea / Bhakta, Nickhill / Bhattacharyya, Krittika / Biadgo, Belete / Bijani, Ali / Bin Sayeed, Muhammad Shahdaat / Birungi, Charles / Bisignano, Catherine / Bitew, Helen / Bjørge, Tone / Bleyer, Archie / Bogale, Kassawmar Angaw / Bojia, Hunduma Amensisa / Borzì, Antonio M / Bosetti, Cristina / Bou-Orm, Ibrahim R / Brenner, Hermann / Brewer, Jerry D / Briko, Andrey Nikolaevich / Briko, Nikolay Ivanovich / Bustamante-Teixeira, Maria Teresa / Butt, Zahid A / Carreras, Giulia / Carrero, Juan J / Carvalho, Félix / Castro, Clara / Castro, Franz / Catalá-López, Ferrán / Cerin, Ester / Chaiah, Yazan / Chanie, Wagaye Fentahun / Chattu, Vijay Kumar / Chaturvedi, Pankaj / Chauhan, Neelima Singh / Chehrazi, Mohammad / Chiang, Peggy Pei-Chia / Chichiabellu, Tesfaye Yitna / Chido-Amajuoyi, Onyema Greg / Chimed-Ochir, Odgerel / Choi, Jee-Young J / Christopher, Devasahayam J / Chu, Dinh-Toi / Constantin, Maria-Magdalena / Costa, Vera M / Crocetti, Emanuele / Crowe, Christopher Stephen / Curado, Maria Paula / Dahlawi, Saad M A / Damiani, Giovanni / Darwish, Amira Hamed / Daryani, Ahmad / das Neves, José / Demeke, Feleke Mekonnen / Demis, Asmamaw Bizuneh / Demissie, Birhanu Wondimeneh / Demoz, Gebre Teklemariam / Denova-Gutiérrez, Edgar / Derakhshani, Afshin / Deribe, Kalkidan Solomon / Desai, Rupak / Desalegn, Beruk Berhanu / Desta, Melaku / Dey, Subhojit / Dharmaratne, Samath Dhamminda / Dhimal, Meghnath / Diaz, Daniel / Dinberu, Mesfin Tadese Tadese / Djalalinia, Shirin / Doku, David Teye / Drake, Thomas M / Dubey, Manisha / Dubljanin, Eleonora / Duken, Eyasu Ejeta / Ebrahimi, Hedyeh / Effiong, Andem / Eftekhari, Aziz / El Sayed, Iman / Zaki, Maysaa El Sayed / El-Jaafary, Shaimaa I / El-Khatib, Ziad / Elemineh, Demelash Abewa / Elkout, Hajer / Ellenbogen, Richard G / Elsharkawy, Aisha / Emamian, Mohammad Hassan / Endalew, Daniel Adane / Endries, Aman Yesuf / Eshrati, Babak / Fadhil, Ibtihal / Fallah Omrani, Vahid / Faramarzi, Mahbobeh / Farhangi, Mahdieh Abbasalizad / Farioli, Andrea / Farzadfar, Farshad / Fentahun, Netsanet / Fernandes, Eduarda / Feyissa, Garumma Tolu / Filip, Irina / Fischer, Florian / Fisher, James L / Force, Lisa M / Foroutan, Masoud / Freitas, Marisa / Fukumoto, Takeshi / Futran, Neal D / Gallus, Silvano / Gankpe, Fortune Gbetoho / Gayesa, Reta Tsegaye / Gebrehiwot, Tsegaye Tewelde / Gebremeskel, Gebreamlak Gebremedhn / Gedefaw, Getnet Azeze / Gelaw, Belayneh K / Geta, Birhanu / Getachew, Sefonias / Gezae, Kebede Embaye / Ghafourifard, Mansour / Ghajar, Alireza / Ghashghaee, Ahmad / Gholamian, Asadollah / Gill, Paramjit Singh / Ginindza, Themba T G / Girmay, Alem / Gizaw, Muluken / Gomez, Ricardo Santiago / Gopalani, Sameer Vali / Gorini, Giuseppe / Goulart, Bárbara Niegia Garcia / Grada, Ayman / Ribeiro Guerra, Maximiliano / Guimaraes, Andre Luiz Sena / Gupta, Prakash C / Gupta, Rahul / Hadkhale, Kishor / Haj-Mirzaian, Arvin / Haj-Mirzaian, Arya / Hamadeh, Randah R / Hamidi, Samer / Hanfore, Lolemo Kelbiso / Haro, Josep Maria / Hasankhani, Milad / Hasanzadeh, Amir / Hassen, Hamid Yimam / Hay, Roderick J / Hay, Simon I / Henok, Andualem / Henry, Nathaniel J / Herteliu, Claudiu / Hidru, Hagos D / Hoang, Chi Linh / Hole, Michael K / Hoogar, Praveen / Horita, Nobuyuki / Hosgood, H Dean / Hosseini, Mostafa / Hosseinzadeh, Mehdi / Hostiuc, Mihaela / Hostiuc, Sorin / Househ, Mowafa / Hussen, Mohammedaman Mama / Ileanu, Bogdan / Ilic, Milena D / Innos, Kaire / Irvani, Seyed Sina Naghibi / Iseh, Kufre Robert / Islam, Sheikh Mohammed Shariful / Islami, Farhad / Jafari Balalami, Nader / Jafarinia, Morteza / Jahangiry, Leila / Jahani, Mohammad Ali / Jahanmehr, Nader / Jakovljevic, Mihajlo / James, Spencer L / Javanbakht, Mehdi / Jayaraman, Sudha / Jee, Sun Ha / Jenabi, Ensiyeh / Jha, Ravi Prakash / Jonas, Jost B / Jonnagaddala, Jitendra / Joo, Tamas / Jungari, Suresh Banayya / Jürisson, Mikk / Kabir, Ali / Kamangar, Farin / Karch, André / Karimi, Narges / Karimian, Ansar / Kasaeian, Amir / Kasahun, Gebremicheal Gebreslassie / Kassa, Belete / Kassa, Tesfaye Dessale / Kassaw, Mesfin Wudu / Kaul, Anil / Keiyoro, Peter Njenga / Kelbore, Abraham Getachew / Kerbo, Amene Abebe / Khader, Yousef Saleh / Khalilarjmandi, Maryam / Khan, Ejaz Ahmad / Khan, Gulfaraz / Khang, Young-Ho / Khatab, Khaled / Khater, Amir / Khayamzadeh, Maryam / Khazaee-Pool, Maryam / Khazaei, Salman / Khoja, Abdullah T / Khosravi, Mohammad Hossein / Khubchandani, Jagdish / Kianipour, Neda / Kim, Daniel / Kim, Yun Jin / Kisa, Adnan / Kisa, Sezer / Kissimova-Skarbek, Katarzyna / Komaki, Hamidreza / Koyanagi, Ai / Krohn, Kristopher J / Bicer, Burcu Kucuk / Kugbey, Nuworza / Kumar, Vivek / Kuupiel, Desmond / La Vecchia, Carlo / Lad, Deepesh P / Lake, Eyasu Alem / Lakew, Ayenew Molla / Lal, Dharmesh Kumar / Lami, Faris Hasan / Lan, Qing / Lasrado, Savita / Lauriola, Paolo / Lazarus, Jeffrey V / Leigh, James / Leshargie, Cheru Tesema / Liao, Yu / Limenih, Miteku Andualem / Listl, Stefan / Lopez, Alan D / Lopukhov, Platon D / Lunevicius, Raimundas / Madadin, Mohammed / Magdeldin, Sameh / El Razek, Hassan Magdy Abd / Majeed, Azeem / Maleki, Afshin / Malekzadeh, Reza / Manafi, Ali / Manafi, Navid / Manamo, Wondimu Ayele / Mansourian, Morteza / Mansournia, Mohammad Ali / Mantovani, Lorenzo Giovanni / Maroufizadeh, Saman / Martini, Santi Martini S / Mashamba-Thompson, Tivani Phosa / Massenburg, Benjamin Ballard / Maswabi, Motswadi Titus / Mathur, Manu Raj / McAlinden, Colm / McKee, Martin / Meheretu, Hailemariam Abiy Alemu / Mehrotra, Ravi / Mehta, Varshil / Meier, Toni / Melaku, Yohannes A / Meles, Gebrekiros Gebremichael / Meles, Hagazi Gebre / Melese, Addisu / Melku, Mulugeta / Memiah, Peter T N / Mendoza, Walter / Menezes, Ritesh G / Merat, Shahin / Meretoja, Tuomo J / Mestrovic, Tomislav / Miazgowski, Bartosz / Miazgowski, Tomasz / Mihretie, Kebadnew Mulatu M / Miller, Ted R / Mills, Edward J / Mir, Seyed Mostafa / Mirzaei, Hamed / Mirzaei, Hamid Reza / Mishra, Rashmi / Moazen, Babak / Mohammad, Dara K / Mohammad, Karzan Abdulmuhsin / Mohammad, Yousef / Darwesh, Aso Mohammad / Mohammadbeigi, Abolfazl / Mohammadi, Hiwa / Mohammadi, Moslem / Mohammadian, Mahdi / Mohammadian-Hafshejani, Abdollah / Mohammadoo-Khorasani, Milad / Mohammadpourhodki, Reza / Mohammed, Ammas Siraj / Mohammed, Jemal Abdu / Mohammed, Shafiu / Mohebi, Farnam / Mokdad, Ali H / Monasta, Lorenzo / Moodley, Yoshan / Moosazadeh, Mahmood / Moossavi, Maryam / Moradi, Ghobad / Moradi-Joo, Mohammad / Moradi-Lakeh, Maziar / Moradpour, Farhad / Morawska, Lidia / Morgado-da-Costa, Joana / Morisaki, Naho / Morrison, Shane Douglas / Mosapour, Abbas / Mousavi, Seyyed Meysam / Muche, Achenef Asmamaw / Muhammed, Oumer Sada S / Musa, Jonah / Nabhan, Ashraf F / Naderi, Mehdi / Nagarajan, Ahamarshan Jayaraman / Nagel, Gabriele / Nahvijou, Azin / Naik, Gurudatta / Najafi, Farid / Naldi, Luigi / Nam, Hae Sung / Nasiri, Naser / Nazari, Javad / Negoi, Ionut / Neupane, Subas / Newcomb, Polly A / Nggada, Haruna Asura / Ngunjiri, Josephine W / Nguyen, Cuong Tat / Nikniaz, Leila / Ningrum, Dina Nur Anggraini / Nirayo, Yirga Legesse / Nixon, Molly R / Nnaji, Chukwudi A / Nojomi, Marzieh / Nosratnejad, Shirin / Shiadeh, Malihe Nourollahpour / Obsa, Mohammed Suleiman / Ofori-Asenso, Richard / Ogbo, Felix Akpojene / Oh, In-Hwan / Olagunju, Andrew T / Olagunju, Tinuke O / Oluwasanu, Mojisola Morenike / Omonisi, Abidemi E / Onwujekwe, Obinna E / Oommen, Anu Mary / Oren, Eyal / Ortega-Altamirano, Doris D V / Ota, Erika / Otstavnov, Stanislav S / Owolabi, Mayowa Ojo / P A, Mahesh / Padubidri, Jagadish Rao / Pakhale, Smita / Pakpour, Amir H / Pana, Adrian / Park, Eun-Kee / Parsian, Hadi / Pashaei, Tahereh / Patel, Shanti / Patil, Snehal T / Pennini, Alyssa / Pereira, David M / Piccinelli, Cristiano / Pillay, Julian David / Pirestani, Majid / Pishgar, Farhad / Postma, Maarten J / Pourjafar, Hadi / Pourmalek, Farshad / Pourshams, Akram / Prakash, Swayam / Prasad, Narayan / Qorbani, Mostafa / Rabiee, Mohammad / Rabiee, Navid / Radfar, Amir / Rafiei, Alireza / Rahim, Fakher / Rahimi, Mahdi / Rahman, Muhammad Aziz / Rajati, Fatemeh / Rana, Saleem M / Raoofi, Samira / Rath, Goura Kishor / Rawaf, David Laith / Rawaf, Salman / Reiner, Robert C / Renzaho, Andre M N / Rezaei, Nima / Rezapour, Aziz / Ribeiro, Ana Isabel / Ribeiro, Daniela / Ronfani, Luca / Roro, Elias Merdassa / Roshandel, Gholamreza / Rostami, Ali / Saad, Ragy Safwat / Sabbagh, Parisa / Sabour, Siamak / Saddik, Basema / Safiri, Saeid / Sahebkar, Amirhossein / Salahshoor, Mohammad Reza / Salehi, Farkhonde / Salem, Hosni / Salem, Marwa Rashad / Salimzadeh, Hamideh / Salomon, Joshua A / Samy, Abdallah M / Sanabria, Juan / Santric Milicevic, Milena M / Sartorius, Benn / Sarveazad, Arash / Sathian, Brijesh / Satpathy, Maheswar / Savic, Miloje / Sawhney, Monika / Sayyah, Mehdi / Schneider, Ione J C / Schöttker, Ben / Sekerija, Mario / Sepanlou, Sadaf G / Sepehrimanesh, Masood / Seyedmousavi, Seyedmojtaba / Shaahmadi, Faramarz / Shabaninejad, Hosein / Shahbaz, Mohammad / Shaikh, Masood Ali / Shamshirian, Amir / Shamsizadeh, Morteza / Sharafi, Heidar / Sharafi, Zeinab / Sharif, Mehdi / Sharifi, Ali / Sharifi, Hamid / Sharma, Rajesh / Sheikh, Aziz / Shirkoohi, Reza / Shukla, Sharvari Rahul / Si, Si / Siabani, Soraya / Silva, Diego Augusto Santos / Silveira, Dayane Gabriele Alves / Singh, Ambrish / Singh, Jasvinder A / Sisay, Solomon / Sitas, Freddy / Sobngwi, Eugène / Soofi, Moslem / Soriano, Joan B / Stathopoulou, Vasiliki / Sufiyan, Mu'awiyyah Babale / Tabarés-Seisdedos, Rafael / Tabuchi, Takahiro / Takahashi, Ken / Tamtaji, Omid Reza / Tarawneh, Mohammed Rasoul / Tassew, Segen Gebremeskel / Taymoori, Parvaneh / Tehrani-Banihashemi, Arash / Temsah, Mohamad-Hani / Temsah, Omar / Tesfay, Berhe Etsay / Tesfay, Fisaha Haile / Teshale, Manaye Yihune / Tessema, Gizachew Assefa / Thapa, Subash / Tlaye, Kenean Getaneh / Topor-Madry, Roman / Tovani-Palone, Marcos Roberto / Traini, Eugenio / Tran, Bach Xuan / Tran, Khanh Bao / Tsadik, Afewerki Gebremeskel / Ullah, Irfan / Uthman, Olalekan A / Vacante, Marco / Vaezi, Maryam / Varona Pérez, Patricia / Veisani, Yousef / Vidale, Simone / Violante, Francesco S / Vlassov, Vasily / Vollset, Stein Emil / Vos, Theo / Vosoughi, Kia / Vu, Giang Thu / Vujcic, Isidora S / Wabinga, Henry / Wachamo, Tesfahun Mulatu / Wagnew, Fasil Shiferaw / Waheed, Yasir / Weldegebreal, Fitsum / Weldesamuel, Girmay Teklay / Wijeratne, Tissa / Wondafrash, Dawit Zewdu / Wonde, Tewodros Eshete / Wondmieneh, Adam Belay / Workie, Hailemariam Mekonnen / Yadav, Rajaram / Yadegar, Abbas / Yadollahpour, Ali / Yaseri, Mehdi / Yazdi-Feyzabadi, Vahid / Yeshaneh, Alex / Yimam, Mohammed Ahmed / Yimer, Ebrahim M / Yisma, Engida / Yonemoto, Naohiro / Younis, Mustafa Z / Yousefi, Bahman / Yousefifard, Mahmoud / Yu, Chuanhua / Zabeh, Erfan / Zadnik, Vesna / Moghadam, Telma Zahirian / Zaidi, Zoubida / Zamani, Mohammad / Zandian, Hamed / Zangeneh, Alireza / Zaki, Leila / Zendehdel, Kazem / Zenebe, Zerihun Menlkalew / Zewale, Taye Abuhay / Ziapour, Arash / Zodpey, Sanjay / Murray, Christopher J L

    JAMA oncology

    2019  Volume 5, Issue 12, Page(s) 1749–1768

    Abstract: Importance: Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting ... ...

    Abstract Importance: Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting, and budgeting have been identified as major obstacles in achieving these goals. All of these have in common that they require information on the local cancer epidemiology. The Global Burden of Disease (GBD) study is uniquely poised to provide these crucial data.
    Objective: To describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning.
    Evidence review: We used the GBD study estimation methods to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs). Results are presented at the national level as well as by Socio-demographic Index (SDI), a composite indicator of income, educational attainment, and total fertility rate. We also analyzed the influence of the epidemiological vs the demographic transition on cancer incidence.
    Findings: In 2017, there were 24.5 million incident cancer cases worldwide (16.8 million without nonmelanoma skin cancer [NMSC]) and 9.6 million cancer deaths. The majority of cancer DALYs came from years of life lost (97%), and only 3% came from years lived with disability. The odds of developing cancer were the lowest in the low SDI quintile (1 in 7) and the highest in the high SDI quintile (1 in 2) for both sexes. In 2017, the most common incident cancers in men were NMSC (4.3 million incident cases); tracheal, bronchus, and lung (TBL) cancer (1.5 million incident cases); and prostate cancer (1.3 million incident cases). The most common causes of cancer deaths and DALYs for men were TBL cancer (1.3 million deaths and 28.4 million DALYs), liver cancer (572 000 deaths and 15.2 million DALYs), and stomach cancer (542 000 deaths and 12.2 million DALYs). For women in 2017, the most common incident cancers were NMSC (3.3 million incident cases), breast cancer (1.9 million incident cases), and colorectal cancer (819 000 incident cases). The leading causes of cancer deaths and DALYs for women were breast cancer (601 000 deaths and 17.4 million DALYs), TBL cancer (596 000 deaths and 12.6 million DALYs), and colorectal cancer (414 000 deaths and 8.3 million DALYs).
    Conclusions and relevance: The national epidemiological profiles of cancer burden in the GBD study show large heterogeneities, which are a reflection of different exposures to risk factors, economic settings, lifestyles, and access to care and screening. The GBD study can be used by policy makers and other stakeholders to develop and improve national and local cancer control in order to achieve the global targets and improve equity in cancer care.
    MeSH term(s) Disabled Persons ; Global Burden of Disease ; Global Health ; Humans ; Incidence ; Neoplasms/epidemiology ; Quality-Adjusted Life Years
    Language English
    Publishing date 2019-11-02
    Publishing country United States
    Document type Journal Article
    ISSN 2374-2445
    ISSN (online) 2374-2445
    DOI 10.1001/jamaoncol.2019.2996
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top